Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 08/02 11:37:04 am
68.2 EUR   +0.81%
07/27COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
MD
07/26COMPUGROUP MEDICAL : Baader Bank maintains a Sell rating
MD
07/26COMPUGROUP MEDICAL : Deutsche Bank gives a Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical : successfully completes acquisition of eMDs in the USA

12/21/2020 | 01:17pm EDT

DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Acquisition
CompuGroup Medical successfully completes acquisition of eMDs in the USA

21.12.2020 / 19:16
The issuer is solely responsible for the content of this announcement.


 

  • Transaction completed after regulatory approvals
  • CompuGroup Medical is now one of the leading providers of doctor information systems in the US market
  • Product portfolios complement one another
  • CGM's customer base and sales network continue to grow
  • Investments planned in accelerated growth


Koblenz. CompuGroup Medical SE & Co. KGaA (CGM) is strengthening its international market position and rising to belong to the leading providers of Ambulatory Information Systems in the USA, with the acquisition of eMDs, an Austin, Texas based corporation. CompuGroup Holding USA, Inc., a 100 % subsidiary of CompuGroup Medical SE & Co. KGaA, successfully completed the reverse triangular merger under US law, making this growth opportunity possible. During the course of the closing, all of the company shares will be included in CGM's financial statements as of December 31, 2020.

The main products of eMDs are Ambulatory Information Systems and Revenue Cycle Management.

The acquisition price is around USD 240 million (EUR 203 million). The acquisition price will be financed from cash, current cash flow, and a temporary drawdown of the revolving multi-year loans in the low double-digit million-euro range. In the 2019/2020 fiscal year (ended on March 31, 2020), with more than 60,000 service providers, eMDs generated revenues of around EUR 81 million with an adjusted EBITDA of around EUR 12 million. eMDs currently employs around 1400 staff.

The new, strengthened CGM US company is intended to benefit from current growth in the health IT market in an accelerated manner and simultaneously make the dynamics of this sector in the USA accessible more quickly to all divisions of CompuGroup Medical. For this purpose, investments are particularly planned in the areas of electronic data interchange (EDI) and product development, which are already intended to be implemented in the coming months.

"With eMDs, we are taking our US business to a new dimension. Know-how, products and target markets excellently complement one another," says Frank Gotthardt, founder and CEO of CompuGroup Medical SE & Co. KGaA. The Group, which is domiciled in Germany, is one of the world's leading providers of eHealth solutions. "We are also expanding our sales network with another 100 partners through the acquisition. We are now even better and more broadly positioned, in order to take advantage of the current growth trend in the US market for health IT, for the benefit of patients and health professionals."

Benedikt Brückle, Senior Vice President Northern America of CompuGroup Medical SE & Co. KGaA, "I am looking forward to working with Derek Pickell and his team. We have consistently focused our company on growth and scale over the past years. With the acquisitions of eMDs and the acquisition of Laboratory Information System provider Schuyler House, also completed in December, this will allow us to grow at an above-average and profitable rate in the coming years."

Derek Pickell, CEO of eMDs, emphasizes in his comment: "The investment by CompuGroup Medical gives us all an additional push. With combined forces, we will offer solutions that help our customers, partners and employees to improve services - and thereby serve the health of all patients. I am looking forward to continuing the growth story of eMDs together with Benedikt Brückle and his team now as part of CompuGroup Medical and to advance it significantly stronger together."



About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of EUR 746 million in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 8,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system (including the now counted employees of eMDs).



Contact for media representatives:
Michael Franz
Head of Brand Communication
P +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
E-mail: press@cgm.com


Contact for analysts and investors:
Claudia Thomé
Head of Investor Relations
P +49 (0) 261 8000-7030
F +49 (0) 261 8000-3200
E-mail: claudia.thome@cgm.com



21.12.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1156762

 
End of News DGAP News Service

1156762  21.12.2020 

fncls.ssp?fn=show_t_gif&application_id=1156762&application_name=news&site_id=zonebourse_sftp

ę EQS 2020
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
07/27COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
MD
07/26COMPUGROUP MEDICAL : Baader Bank maintains a Sell rating
MD
07/26COMPUGROUP MEDICAL : Deutsche Bank gives a Buy rating
MD
07/22COMPUGROUP MEDICAL : KoCoBox MED+ obtains approval as an electronic health recor..
EQ
07/22CompuGroup Medical Receives Kocobox MED+ Obtains Approval as an Electronic He..
CI
07/19COMPUGROUP MEDICAL SE & CO. KGAA : Preliminary announcement of the publication o..
EQ
06/17COMPUGROUP MEDICAL SE & CO. KGAA : Release according to Article 40, Section 1 of..
EQ
06/14COMPUGROUP MEDICAL : Company Presentation June
PU
06/02COMPUGROUP MEDICAL : Receives a Sell rating from Baader Bank
MD
06/01CompuGroup Medical SE & Co. KGaA acquired Visus Health It Gmbh.
CI
More news
Financials
Sales 2021 1 019 M 1 210 M 1 210 M
Net income 2021 79,5 M 94,4 M 94,4 M
Net Debt 2021 430 M 511 M 511 M
P/E ratio 2021 45,8x
Yield 2021 0,74%
Capitalization 3 592 M 4 261 M 4 266 M
EV / Sales 2021 3,95x
EV / Sales 2022 3,69x
Nbr of Employees 7 534
Free-Float 48,9%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | COP | DE0005437305 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 67,65 €
Average target price 80,19 €
Spread / Average Target 18,5%
EPS Revisions
Managers and Directors
Dirk Woessner Chairman-Management Board & CEO
Michael Rauch Chief Financial Officer
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Hannes Reichl Managing Director-Clinical & Social Care
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA-13.93%4 261
ORACLE CORPORATION34.70%243 295
SAP SE12.70%169 087
INTUIT INC.39.52%144 819
SERVICENOW, INC.6.81%116 482
DOCUSIGN, INC.34.07%58 069